Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Biological activity of a combination of fulvestrant 500 mg (F500) plus anastrozole versus F500 alone or anastrozole alone as neoadjuvant treatment for breast cancer [Abstract]

Robertson, J. F. R., Dixon, J. M., Sibbering, D. M., Jahan, A., Ellis, I. O., Channon, E., Nicholson, Robert Ian and Gee, Julia Margaret Wendy 2010. Biological activity of a combination of fulvestrant 500 mg (F500) plus anastrozole versus F500 alone or anastrozole alone as neoadjuvant treatment for breast cancer [Abstract]. EJC Supplements 8 (3) , p. 63. 10.1016/S1359-6349(10)70050-1

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
Additional Information: Abstract Book EBCC7 - European Breast Cancer Conference
Publisher: Elsevier
ISSN: 1359-6349
Last Modified: 04 Jun 2017 03:07
URI: http://orca-mwe.cf.ac.uk/id/eprint/17110

Actions (repository staff only)

Edit Item Edit Item